Literature DB >> 8818400

Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

G Fink1, B E Sumner, R Rosie, O Grace, J P Quinn.   

Abstract

1. Estrogen exerts profound effects on mood, mental state and memory by acting on both "classical" monoamine and neuropeptide transmitter mechanisms in brain. Here we review an example of each type of action. 2. With respect to the effect of estrogen on central monoamine neurotransmission, low levels of estrogen in women are associated with the premenstrual syndrome, postnatal depression and post-menopausal depression. Sex differences in schizophrenia have also been attributed to estrogen. Previous studies have shown that estrogen stimulates a significant increase in dopamine2 (D2) receptors in the striatum. Here we show for the first time that estrogen also stimulates a significant increase in the density of 5-hydroxytryptamine2A (5-HT2A) binding sites in anterior frontal, cingulate and primary olfactory cortex and in the nucleus accumbens, areas of the brain concerned with the control of mood, mental state, cognition, emotion and behavior. These findings explain, for example, the efficacy of estrogen therapy or 5-HT uptake blockers such as fluoxetine in treating the depressive symptoms of the premenstrual syndrome. and suggest that the sex differences in schizophrenia may also be due to an action of estrogen mediated by way of 5-HT2A receptors. 3. With respect to the effect of estrogen on central neuropeptide transmission, estrogen stimulates the expression of the arginine vasopressin (AVP) gene in the bed nucleus of the stria terminalis (BNST) in rodents. This results in a 100-fold increase in AVP mRNA in the BNST and a massive increase in AVP peptide in the BNST and its projections to the lateral septum and lateral habenula. The BNST-AVP system enhances and/or maintains "social" or "olfactory" memory, and thus provides a powerful model for correlating transcriptional control of neuropeptide gene expression with behavior. Whether similar mechanisms operate in the human remain to be determined. 4. These two examples of the action of estrogen on central neurotransmission are discussed in terms of their immediate clinical importance for the treatment of depressive symptoms, their use as powerful models for investigations on the steroid control of central neurotransmitter mechanisms, and the role of estrogen as "Nature's" psychoprotectant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818400     DOI: 10.1007/bf02088099

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  72 in total

Review 1.  Neuroendocrine control of gonadotrophin secretion.

Authors:  G Fink
Journal:  Br Med Bull       Date:  1979-05       Impact factor: 4.291

Review 2.  On the significance of subterritories in the "accumbens" part of the rat ventral striatum.

Authors:  D S Zahm; J S Brog
Journal:  Neuroscience       Date:  1992-10       Impact factor: 3.590

Review 3.  Muscle basic helix-loop-helix proteins and the regulation of myogenesis.

Authors:  W E Wright
Journal:  Curr Opin Genet Dev       Date:  1992-04       Impact factor: 5.578

4.  Gonadotropin-releasing hormone surge: possible modulation through postsynaptic alpha-adrenoreceptors and two pharmacologically distinct dopamine receptors.

Authors:  D K Sarkar; G Fink
Journal:  Endocrinology       Date:  1981-03       Impact factor: 4.736

5.  The symptomatology of puerperal illnesses.

Authors:  C Dean; R E Kendell
Journal:  Br J Psychiatry       Date:  1981-08       Impact factor: 9.319

6.  Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.

Authors:  N M Appel; W M Mitchell; R K Garlick; R A Glennon; M Teitler; E B De Souza
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

7.  Septal vasopressin modulates social memory in male rats.

Authors:  R Dantzer; G F Koob; R M Bluthé; M Le Moal
Journal:  Brain Res       Date:  1988-08-02       Impact factor: 3.252

8.  Effects of androgens and estrogens on the vasopressin and oxytocin innervation of the adult rat brain.

Authors:  G J de Vries; W Duetz; R M Buijs; J van Heerikhuize; J T Vreeburg
Journal:  Brain Res       Date:  1986-12-10       Impact factor: 3.252

Review 9.  Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia.

Authors:  H Häfner; A Riecher-Rössler; W An Der Heiden; K Maurer; B Fätkenheuer; W Löffler
Journal:  Psychol Med       Date:  1993-11       Impact factor: 7.723

10.  Gender and the course of schizophrenia: differences in treated outcomes.

Authors:  M C Angermeyer; L Kühn; J M Goldstein
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

View more
  85 in total

Review 1.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

2.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

3.  Thyroid hormone can increase estrogen-mediated transcription from a consensus estrogen response element in neuroblastoma cells.

Authors:  Xing Zhao; Heather Lorenc; Heather Stephenson; Yunjiao Joy Wang; Dawn Witherspoon; Benita Katzenellenbogen; Donald Pfaff; Nandini Vasudevan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-18       Impact factor: 11.205

4.  Estrogen-modulated frontal cortical CaMKII activity and behavioral supersensitization induced by prolonged cocaine treatment in female rats.

Authors:  Xuechu Zhen; Satindra Goswami; Syed Amir Abdali; Maya Frankfurt; Eitan Friedman
Journal:  Psychopharmacology (Berl)       Date:  2006-12-12       Impact factor: 4.530

5.  Changes in estrogen receptor-alpha mRNA in the mouse cortex during development.

Authors:  Amanda K Prewitt; Melinda E Wilson
Journal:  Brain Res       Date:  2007-01-17       Impact factor: 3.252

6.  The dynamic serotonin system of the maternal brain.

Authors:  Joseph S Lonstein
Journal:  Arch Womens Ment Health       Date:  2018-07-21       Impact factor: 3.633

Review 7.  Using animal models to study post-partum psychiatric disorders.

Authors:  C V Perani; D A Slattery
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

8.  Progesterone reduces the effect of the serotonin 1B/1D receptor antagonist, GR 127935, on lordosis behavior.

Authors:  Lynda Uphouse; Cindy Hiegel; Jutatip Guptarak; Navin Maswood
Journal:  Horm Behav       Date:  2008-10-08       Impact factor: 3.587

9.  The number of cells expressing dopamine D2 receptor mRNA in rat brain caudate putamen is higher in oestrus.

Authors:  Matjaz Ursic; Srdan V Bavdek; Jelka Zabavnik
Journal:  J Anat       Date:  2003-05       Impact factor: 2.610

10.  Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats.

Authors:  B Meyers; A D'Agostino; J Walker; M F Kritzer
Journal:  Neuroscience       Date:  2009-11-10       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.